Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus-Peter Janssen

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Signal Transduction and Targeted Therapy|September 8, 2024
Metabolic inflexibility of mitochondria: beneficial for the fitness of regenerating liver cellsJosef Ecker, Sarah Brunner, Klaus-Peter Janssen
Gastroenterology|November 10, 2021
ReplyJosef Ecker, Gerhard Liebisch, Klaus-Peter Janssen
Signal Transduction and Targeted Therapy|July 2, 2024
Boosting liver regeneration: kinase inhibitor as a new tool to prevent liver failureAnna Sichler, Norbert Hüser, Klaus-Peter Janssen
Signal Transduction and Targeted Therapy|November 11, 2024
Post-fast refeeding: rise of intestinal stemness and mutagen-induced cancer risk through polyamine metabolismSarah Brunner, Klaus-Peter Janssen, Josef Ecker
Ebiomedicine|January 11, 2025
Liver regeneration in fatty liver disease: can metabolomics shed light on the contribution of the gut microbiome?Florian Jokisch, Laura Jennifer Marie Geyer, Klaus-Peter Janssen
Experimental Cell Research|October 27, 2009
Tumor endothelial marker 5 expression in endothelial cells during capillary morphogenesis is induced by the small GTPase Rac and mediates contact inhibition of cell proliferationMario Vallon, Franziska Rohde, Klaus-Peter Janssen, et al.
The Biochemical Journal|October 22, 2011
Thrombin-induced shedding of tumour endothelial marker 5 and exposure of its RGD motif are regulated by cell-surface protein disulfide-isomeraseMario Vallon, Philipp Aubele, Klaus-Peter Janssen, et al.
Oncoimmunology|September 18, 2018
Cell-type specific MyD88 signaling is required for intestinal tumor initiation and progression to malignancyAnne Holtorf, Anja Conrad, Bernhard Holzmann, et al.
The International Journal of Biochemistry & Cell Biology|August 9, 2011
The candidate tumor suppressor SASH1 interacts with the actin cytoskeleton and stimulates cell-matrix adhesionMelanie Martini, Alexandra Gnann, Daniela Scheikl, et al.
Oncotarget|November 23, 2017
Interferon-inducible CXC-chemokines are crucial immune modulators and survival predictors in colorectal cancerLarissa Kistner, Dietrich Doll, Anne Holtorf, et al.
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Signal Transduction and Targeted Therapy|September 8, 2024
Metabolic inflexibility of mitochondria: beneficial for the fitness of regenerating liver cellsJosef Ecker, Sarah Brunner, Klaus-Peter Janssen
Gastroenterology|November 10, 2021
ReplyJosef Ecker, Gerhard Liebisch, Klaus-Peter Janssen
Signal Transduction and Targeted Therapy|July 2, 2024
Boosting liver regeneration: kinase inhibitor as a new tool to prevent liver failureAnna Sichler, Norbert Hüser, Klaus-Peter Janssen
Signal Transduction and Targeted Therapy|November 11, 2024
Post-fast refeeding: rise of intestinal stemness and mutagen-induced cancer risk through polyamine metabolismSarah Brunner, Klaus-Peter Janssen, Josef Ecker
Ebiomedicine|January 11, 2025
Liver regeneration in fatty liver disease: can metabolomics shed light on the contribution of the gut microbiome?Florian Jokisch, Laura Jennifer Marie Geyer, Klaus-Peter Janssen
Experimental Cell Research|October 27, 2009
Tumor endothelial marker 5 expression in endothelial cells during capillary morphogenesis is induced by the small GTPase Rac and mediates contact inhibition of cell proliferationMario Vallon, Franziska Rohde, Klaus-Peter Janssen, et al.
The Biochemical Journal|October 22, 2011
Thrombin-induced shedding of tumour endothelial marker 5 and exposure of its RGD motif are regulated by cell-surface protein disulfide-isomeraseMario Vallon, Philipp Aubele, Klaus-Peter Janssen, et al.
Oncoimmunology|September 18, 2018
Cell-type specific MyD88 signaling is required for intestinal tumor initiation and progression to malignancyAnne Holtorf, Anja Conrad, Bernhard Holzmann, et al.
The International Journal of Biochemistry & Cell Biology|August 9, 2011
The candidate tumor suppressor SASH1 interacts with the actin cytoskeleton and stimulates cell-matrix adhesionMelanie Martini, Alexandra Gnann, Daniela Scheikl, et al.
Oncotarget|November 23, 2017
Interferon-inducible CXC-chemokines are crucial immune modulators and survival predictors in colorectal cancerLarissa Kistner, Dietrich Doll, Anne Holtorf, et al.
Pageof 13